FDA Adverse Event Injury Summary report: N

CRYOBALLOON ABLATION SYSTEM

MDR report key: 6762287 · Received August 2, 2017

Report

Report Number
3008780134-2017-00010
Event Type
Injury
Date Received
August 2, 2017
Date of Event
April 21, 2017
Report Date
July 17, 2017
Manufacturer
C2 THERAPEUTICS INC
Product Code
GEH
PMA / PMN Number
K161202
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
DC, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE ADVERSE EVENT WAS PROBABLY RELATED TO THE PATIENT TAKING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) AS THESE DRUGS CAN INCREASE THE RISK OF STOMACH AND INTESTINAL ADVERSE REACTIONS SUCH AS BLEEDING OR ULCERS.

Description of Event or Problem · 1

PATIENT ORIGINALLY UNDERWENT CRYOABLATION PROCEDURE WITH THE C2 CRYOBALLOON ABLATION SYSTEM ON (B)(6) 2017. APPROXIMATELY 2 WEEKS AFTER THE PROCEDURE THE PATIENT REPORTED EXPERIENCING SYNCOPE (FAINTING) WHILE ABROAD IN (B)(6) AND WAS AIRLIFTED TO (B)(6). THE PATIENT PRESENTED WITH MELENA (DARK, STICKY FECES CONTAINING PARTIALLY DIGESTED BLOOD) BUT WAS NOT TRANSFUSED. THIS EVENT WAS NOT REPORTED TO C2 THERAPEUTICS. THE PATIENT REPORTED THAT DURING THIS PERIOD HE WAS ON NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) AND WAS NOT COMPLIANT WITH HIS PROTON-PUMP INHIBITOR (PPI). THE PHYSICIAN STATED THAT IT WAS UNCLEAR IF THE CRYOABLATION SITE BLED OR OF IT WAS A PEPTIC ULCER THAT BLED AND THAT NO BLEEDING WAS SEEN WHEN THE PATIENT WAS RE-SCOPED IN (B)(6). THE PHYSICIAN STRESSED THAT THE NSAIDS MAY HAVE EXACERBATED THE BLEEDING. THE PATIENT UNDERWENT A SECOND CRYOABLATION PROCEDURE USING THE C2 CRYOBALLOON ABLATION SYSTEM ON (B)(6) 2017 FOR 3, 10-SECOND ABLATIONS. THE PATIENT APPEARED TO HAVE SOME NARROWING OF THE ESOPHAGUS OR POSSIBLE STRICTURE, BUT DID NOT REPORT ANY DIFFICULTY SWALLOWING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
540722 CRYOBALLOON ABLATION SYSTEM CRYOSURGICAL UNIT WITH ACCESSORIES, PRODUCT CODE: GEH GEH C2 THERAPEUTICS INC FG 1012 UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 Other